Report Overview
KRAS inhibitors are a class of targeted cancer therapies designed to block the activity of the KRAS protein, a common driver of cancer, particularly in pancreatic, colorectal, and lung cancers. KRAS mutations are notoriously difficult to target because the protein has a smooth surface with few pockets for drug binding. However, recent advances have led to the development of specific inhibitors, such as sotorasib and adagrasib, which target the G12C mutation in KRAS, a mutation present in a subset of cancers. These inhibitors work by irreversibly binding to the mutant KRAS protein, preventing it from signaling the uncontrolled cell growth that leads to cancer. While these drugs have shown promise, they are not universally effective, and resistance often develops, leading to ongoing research to improve their efficacy and expand their use to other KRAS mutations.
The global KRAS Inhibitor market size was estimated at USD 121 million in 2023 and is projected to reach USD 247.99 million by 2032, exhibiting a CAGR of 8.30% during the forecast period.
North America KRAS Inhibitor market size was estimated at USD 36.17 million in 2023, at a CAGR of 7.11% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global KRAS Inhibitor market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global KRAS Inhibitor Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the KRAS Inhibitor market in any manner.
Global KRAS Inhibitor Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Amgen
Boehringer Ingelheim
BridgeBio Pharma
Erasca
Innovent Biologics
Incyte
Mirati Therapeutics
Novartis
Jemincare
Cardiff Oncology
Market Segmentation (by Type)
Lung Cancer
Pancreatic Cancer
Colorectal Cancer
Others
Market Segmentation (by Application)
Clinic Laboratories
Cancer Diagnostic Centres
Hospitals
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the KRAS Inhibitor Market
Overview of the regional outlook of the KRAS Inhibitor Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the KRAS Inhibitor Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of KRAS Inhibitor, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of KRAS Inhibitor
1.2 Key Market Segments
1.2.1 KRAS Inhibitor Segment by Type
1.2.2 KRAS Inhibitor Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 KRAS Inhibitor Market Overview
2.1 Global Market Overview
2.1.1 Global KRAS Inhibitor Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global KRAS Inhibitor Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 KRAS Inhibitor Market Competitive Landscape
3.1 Global KRAS Inhibitor Sales by Manufacturers (2019-2025)
3.2 Global KRAS Inhibitor Revenue Market Share by Manufacturers (2019-2025)
3.3 KRAS Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global KRAS Inhibitor Average Price by Manufacturers (2019-2025)
3.5 Manufacturers KRAS Inhibitor Sales Sites, Area Served, Product Type
3.6 KRAS Inhibitor Market Competitive Situation and Trends
3.6.1 KRAS Inhibitor Market Concentration Rate
3.6.2 Global 5 and 10 Largest KRAS Inhibitor Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 KRAS Inhibitor Industry Chain Analysis
4.1 KRAS Inhibitor Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of KRAS Inhibitor Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 KRAS Inhibitor Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global KRAS Inhibitor Sales Market Share by Type (2019-2025)
6.3 Global KRAS Inhibitor Market Size Market Share by Type (2019-2025)
6.4 Global KRAS Inhibitor Price by Type (2019-2025)
7 KRAS Inhibitor Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global KRAS Inhibitor Market Sales by Application (2019-2025)
7.3 Global KRAS Inhibitor Market Size (M USD) by Application (2019-2025)
7.4 Global KRAS Inhibitor Sales Growth Rate by Application (2019-2025)
8 KRAS Inhibitor Market Consumption by Region
8.1 Global KRAS Inhibitor Sales by Region
8.1.1 Global KRAS Inhibitor Sales by Region
8.1.2 Global KRAS Inhibitor Sales Market Share by Region
8.2 North America
8.2.1 North America KRAS Inhibitor Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe KRAS Inhibitor Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific KRAS Inhibitor Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America KRAS Inhibitor Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa KRAS Inhibitor Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KRAS Inhibitor Market Production by Region
9.1 Global Production of KRAS Inhibitor by Region (2019-2025)
9.2 Global KRAS Inhibitor Revenue Market Share by Region (2019-2025)
9.3 Global KRAS Inhibitor Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America KRAS Inhibitor Production
9.4.1 North America KRAS Inhibitor Production Growth Rate (2019-2025)
9.4.2 North America KRAS Inhibitor Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe KRAS Inhibitor Production
9.5.1 Europe KRAS Inhibitor Production Growth Rate (2019-2025)
9.5.2 Europe KRAS Inhibitor Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan KRAS Inhibitor Production (2019-2025)
9.6.1 Japan KRAS Inhibitor Production Growth Rate (2019-2025)
9.6.2 Japan KRAS Inhibitor Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China KRAS Inhibitor Production (2019-2025)
9.7.1 China KRAS Inhibitor Production Growth Rate (2019-2025)
9.7.2 China KRAS Inhibitor Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Amgen
10.1.1 Amgen KRAS Inhibitor Basic Information
10.1.2 Amgen KRAS Inhibitor Product Overview
10.1.3 Amgen KRAS Inhibitor Product Market Performance
10.1.4 Amgen Business Overview
10.1.5 Amgen KRAS Inhibitor SWOT Analysis
10.1.6 Amgen Recent Developments
10.2 Boehringer Ingelheim
10.2.1 Boehringer Ingelheim KRAS Inhibitor Basic Information
10.2.2 Boehringer Ingelheim KRAS Inhibitor Product Overview
10.2.3 Boehringer Ingelheim KRAS Inhibitor Product Market Performance
10.2.4 Boehringer Ingelheim Business Overview
10.2.5 Boehringer Ingelheim KRAS Inhibitor SWOT Analysis
10.2.6 Boehringer Ingelheim Recent Developments
10.3 BridgeBio Pharma
10.3.1 BridgeBio Pharma KRAS Inhibitor Basic Information
10.3.2 BridgeBio Pharma KRAS Inhibitor Product Overview
10.3.3 BridgeBio Pharma KRAS Inhibitor Product Market Performance
10.3.4 BridgeBio Pharma KRAS Inhibitor SWOT Analysis
10.3.5 BridgeBio Pharma Business Overview
10.3.6 BridgeBio Pharma Recent Developments
10.4 Erasca
10.4.1 Erasca KRAS Inhibitor Basic Information
10.4.2 Erasca KRAS Inhibitor Product Overview
10.4.3 Erasca KRAS Inhibitor Product Market Performance
10.4.4 Erasca Business Overview
10.4.5 Erasca Recent Developments
10.5 Innovent Biologics
10.5.1 Innovent Biologics KRAS Inhibitor Basic Information
10.5.2 Innovent Biologics KRAS Inhibitor Product Overview
10.5.3 Innovent Biologics KRAS Inhibitor Product Market Performance
10.5.4 Innovent Biologics Business Overview
10.5.5 Innovent Biologics Recent Developments
10.6 Incyte
10.6.1 Incyte KRAS Inhibitor Basic Information
10.6.2 Incyte KRAS Inhibitor Product Overview
10.6.3 Incyte KRAS Inhibitor Product Market Performance
10.6.4 Incyte Business Overview
10.6.5 Incyte Recent Developments
10.7 Mirati Therapeutics
10.7.1 Mirati Therapeutics KRAS Inhibitor Basic Information
10.7.2 Mirati Therapeutics KRAS Inhibitor Product Overview
10.7.3 Mirati Therapeutics KRAS Inhibitor Product Market Performance
10.7.4 Mirati Therapeutics Business Overview
10.7.5 Mirati Therapeutics Recent Developments
10.8 Novartis
10.8.1 Novartis KRAS Inhibitor Basic Information
10.8.2 Novartis KRAS Inhibitor Product Overview
10.8.3 Novartis KRAS Inhibitor Product Market Performance
10.8.4 Novartis Business Overview
10.8.5 Novartis Recent Developments
10.9 Jemincare
10.9.1 Jemincare KRAS Inhibitor Basic Information
10.9.2 Jemincare KRAS Inhibitor Product Overview
10.9.3 Jemincare KRAS Inhibitor Product Market Performance
10.9.4 Jemincare Business Overview
10.9.5 Jemincare Recent Developments
10.10 Cardiff Oncology
10.10.1 Cardiff Oncology KRAS Inhibitor Basic Information
10.10.2 Cardiff Oncology KRAS Inhibitor Product Overview
10.10.3 Cardiff Oncology KRAS Inhibitor Product Market Performance
10.10.4 Cardiff Oncology Business Overview
10.10.5 Cardiff Oncology Recent Developments
11 KRAS Inhibitor Market Forecast by Region
11.1 Global KRAS Inhibitor Market Size Forecast
11.2 Global KRAS Inhibitor Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe KRAS Inhibitor Market Size Forecast by Country
11.2.3 Asia Pacific KRAS Inhibitor Market Size Forecast by Region
11.2.4 South America KRAS Inhibitor Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of KRAS Inhibitor by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global KRAS Inhibitor Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of KRAS Inhibitor by Type (2025-2032)
12.1.2 Global KRAS Inhibitor Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of KRAS Inhibitor by Type (2025-2032)
12.2 Global KRAS Inhibitor Market Forecast by Application (2025-2032)
12.2.1 Global KRAS Inhibitor Sales (K Units) Forecast by Application
12.2.2 Global KRAS Inhibitor Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. KRAS Inhibitor Market Size Comparison by Region (M USD)
Table 5. Global KRAS Inhibitor Sales (K Units) by Manufacturers (2019-2025)
Table 6. Global KRAS Inhibitor Sales Market Share by Manufacturers (2019-2025)
Table 7. Global KRAS Inhibitor Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global KRAS Inhibitor Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in KRAS Inhibitor as of 2022)
Table 10. Global Market KRAS Inhibitor Average Price (USD/Unit) of Key Manufacturers (2019-2025)
Table 11. Manufacturers KRAS Inhibitor Sales Sites and Area Served
Table 12. Manufacturers KRAS Inhibitor Product Type
Table 13. Global KRAS Inhibitor Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of KRAS Inhibitor
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. KRAS Inhibitor Market Challenges
Table 22. Global KRAS Inhibitor Sales by Type (K Units)
Table 23. Global KRAS Inhibitor Market Size by Type (M USD)
Table 24. Global KRAS Inhibitor Sales (K Units) by Type (2019-2025)
Table 25. Global KRAS Inhibitor Sales Market Share by Type (2019-2025)
Table 26. Global KRAS Inhibitor Market Size (M USD) by Type (2019-2025)
Table 27. Global KRAS Inhibitor Market Size Share by Type (2019-2025)
Table 28. Global KRAS Inhibitor Price (USD/Unit) by Type (2019-2025)
Table 29. Global KRAS Inhibitor Sales (K Units) by Application
Table 30. Global KRAS Inhibitor Market Size by Application
Table 31. Global KRAS Inhibitor Sales by Application (2019-2025) & (K Units)
Table 32. Global KRAS Inhibitor Sales Market Share by Application (2019-2025)
Table 33. Global KRAS Inhibitor Sales by Application (2019-2025) & (M USD)
Table 34. Global KRAS Inhibitor Market Share by Application (2019-2025)
Table 35. Global KRAS Inhibitor Sales Growth Rate by Application (2019-2025)
Table 36. Global KRAS Inhibitor Sales by Region (2019-2025) & (K Units)
Table 37. Global KRAS Inhibitor Sales Market Share by Region (2019-2025)
Table 38. North America KRAS Inhibitor Sales by Country (2019-2025) & (K Units)
Table 39. Europe KRAS Inhibitor Sales by Country (2019-2025) & (K Units)
Table 40. Asia Pacific KRAS Inhibitor Sales by Region (2019-2025) & (K Units)
Table 41. South America KRAS Inhibitor Sales by Country (2019-2025) & (K Units)
Table 42. Middle East and Africa KRAS Inhibitor Sales by Region (2019-2025) & (K Units)
Table 43. Global KRAS Inhibitor Production (K Units) by Region (2019-2025)
Table 44. Global KRAS Inhibitor Revenue (US$ Million) by Region (2019-2025)
Table 45. Global KRAS Inhibitor Revenue Market Share by Region (2019-2025)
Table 46. Global KRAS Inhibitor Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 47. North America KRAS Inhibitor Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 48. Europe KRAS Inhibitor Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 49. Japan KRAS Inhibitor Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 50. China KRAS Inhibitor Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 51. Amgen KRAS Inhibitor Basic Information
Table 52. Amgen KRAS Inhibitor Product Overview
Table 53. Amgen KRAS Inhibitor Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 54. Amgen Business Overview
Table 55. Amgen KRAS Inhibitor SWOT Analysis
Table 56. Amgen Recent Developments
Table 57. Boehringer Ingelheim KRAS Inhibitor Basic Information
Table 58. Boehringer Ingelheim KRAS Inhibitor Product Overview
Table 59. Boehringer Ingelheim KRAS Inhibitor Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 60. Boehringer Ingelheim Business Overview
Table 61. Boehringer Ingelheim KRAS Inhibitor SWOT Analysis
Table 62. Boehringer Ingelheim Recent Developments
Table 63. BridgeBio Pharma KRAS Inhibitor Basic Information
Table 64. BridgeBio Pharma KRAS Inhibitor Product Overview
Table 65. BridgeBio Pharma KRAS Inhibitor Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 66. BridgeBio Pharma KRAS Inhibitor SWOT Analysis
Table 67. BridgeBio Pharma Business Overview
Table 68. BridgeBio Pharma Recent Developments
Table 69. Erasca KRAS Inhibitor Basic Information
Table 70. Erasca KRAS Inhibitor Product Overview
Table 71. Erasca KRAS Inhibitor Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 72. Erasca Business Overview
Table 73. Erasca Recent Developments
Table 74. Innovent Biologics KRAS Inhibitor Basic Information
Table 75. Innovent Biologics KRAS Inhibitor Product Overview
Table 76. Innovent Biologics KRAS Inhibitor Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 77. Innovent Biologics Business Overview
Table 78. Innovent Biologics Recent Developments
Table 79. Incyte KRAS Inhibitor Basic Information
Table 80. Incyte KRAS Inhibitor Product Overview
Table 81. Incyte KRAS Inhibitor Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 82. Incyte Business Overview
Table 83. Incyte Recent Developments
Table 84. Mirati Therapeutics KRAS Inhibitor Basic Information
Table 85. Mirati Therapeutics KRAS Inhibitor Product Overview
Table 86. Mirati Therapeutics KRAS Inhibitor Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 87. Mirati Therapeutics Business Overview
Table 88. Mirati Therapeutics Recent Developments
Table 89. Novartis KRAS Inhibitor Basic Information
Table 90. Novartis KRAS Inhibitor Product Overview
Table 91. Novartis KRAS Inhibitor Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 92. Novartis Business Overview
Table 93. Novartis Recent Developments
Table 94. Jemincare KRAS Inhibitor Basic Information
Table 95. Jemincare KRAS Inhibitor Product Overview
Table 96. Jemincare KRAS Inhibitor Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 97. Jemincare Business Overview
Table 98. Jemincare Recent Developments
Table 99. Cardiff Oncology KRAS Inhibitor Basic Information
Table 100. Cardiff Oncology KRAS Inhibitor Product Overview
Table 101. Cardiff Oncology KRAS Inhibitor Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 102. Cardiff Oncology Business Overview
Table 103. Cardiff Oncology Recent Developments
Table 104. Global KRAS Inhibitor Sales Forecast by Region (2025-2032) & (K Units)
Table 105. Global KRAS Inhibitor Market Size Forecast by Region (2025-2032) & (M USD)
Table 106. North America KRAS Inhibitor Sales Forecast by Country (2025-2032) & (K Units)
Table 107. North America KRAS Inhibitor Market Size Forecast by Country (2025-2032) & (M USD)
Table 108. Europe KRAS Inhibitor Sales Forecast by Country (2025-2032) & (K Units)
Table 109. Europe KRAS Inhibitor Market Size Forecast by Country (2025-2032) & (M USD)
Table 110. Asia Pacific KRAS Inhibitor Sales Forecast by Region (2025-2032) & (K Units)
Table 111. Asia Pacific KRAS Inhibitor Market Size Forecast by Region (2025-2032) & (M USD)
Table 112. South America KRAS Inhibitor Sales Forecast by Country (2025-2032) & (K Units)
Table 113. South America KRAS Inhibitor Market Size Forecast by Country (2025-2032) & (M USD)
Table 114. Middle East and Africa KRAS Inhibitor Consumption Forecast by Country (2025-2032) & (Units)
Table 115. Middle East and Africa KRAS Inhibitor Market Size Forecast by Country (2025-2032) & (M USD)
Table 116. Global KRAS Inhibitor Sales Forecast by Type (2025-2032) & (K Units)
Table 117. Global KRAS Inhibitor Market Size Forecast by Type (2025-2032) & (M USD)
Table 118. Global KRAS Inhibitor Price Forecast by Type (2025-2032) & (USD/Unit)
Table 119. Global KRAS Inhibitor Sales (K Units) Forecast by Application (2025-2032)
Table 120. Global KRAS Inhibitor Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of KRAS Inhibitor
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global KRAS Inhibitor Market Size (M USD), 2019-2032
Figure 5. Global KRAS Inhibitor Market Size (M USD) (2019-2032)
Figure 6. Global KRAS Inhibitor Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. KRAS Inhibitor Market Size by Country (M USD)
Figure 11. KRAS Inhibitor Sales Share by Manufacturers in 2023
Figure 12. Global KRAS Inhibitor Revenue Share by Manufacturers in 2023
Figure 13. KRAS Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market KRAS Inhibitor Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by KRAS Inhibitor Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global KRAS Inhibitor Market Share by Type
Figure 18. Sales Market Share of KRAS Inhibitor by Type (2019-2025)
Figure 19. Sales Market Share of KRAS Inhibitor by Type in 2023
Figure 20. Market Size Share of KRAS Inhibitor by Type (2019-2025)
Figure 21. Market Size Market Share of KRAS Inhibitor by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global KRAS Inhibitor Market Share by Application
Figure 24. Global KRAS Inhibitor Sales Market Share by Application (2019-2025)
Figure 25. Global KRAS Inhibitor Sales Market Share by Application in 2023
Figure 26. Global KRAS Inhibitor Market Share by Application (2019-2025)
Figure 27. Global KRAS Inhibitor Market Share by Application in 2023
Figure 28. Global KRAS Inhibitor Sales Growth Rate by Application (2019-2025)
Figure 29. Global KRAS Inhibitor Sales Market Share by Region (2019-2025)
Figure 30. North America KRAS Inhibitor Sales and Growth Rate (2019-2025) & (K Units)
Figure 31. North America KRAS Inhibitor Sales Market Share by Country in 2023
Figure 32. U.S. KRAS Inhibitor Sales and Growth Rate (2019-2025) & (K Units)
Figure 33. Canada KRAS Inhibitor Sales (K Units) and Growth Rate (2019-2025)
Figure 34. Mexico KRAS Inhibitor Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe KRAS Inhibitor Sales and Growth Rate (2019-2025) & (K Units)
Figure 36. Europe KRAS Inhibitor Sales Market Share by Country in 2023
Figure 37. Germany KRAS Inhibitor Sales and Growth Rate (2019-2025) & (K Units)
Figure 38. France KRAS Inhibitor Sales and Growth Rate (2019-2025) & (K Units)
Figure 39. U.K. KRAS Inhibitor Sales and Growth Rate (2019-2025) & (K Units)
Figure 40. Italy KRAS Inhibitor Sales and Growth Rate (2019-2025) & (K Units)
Figure 41. Russia KRAS Inhibitor Sales and Growth Rate (2019-2025) & (K Units)
Figure 42. Asia Pacific KRAS Inhibitor Sales and Growth Rate (K Units)
Figure 43. Asia Pacific KRAS Inhibitor Sales Market Share by Region in 2023
Figure 44. China KRAS Inhibitor Sales and Growth Rate (2019-2025) & (K Units)
Figure 45. Japan KRAS Inhibitor Sales and Growth Rate (2019-2025) & (K Units)
Figure 46. South Korea KRAS Inhibitor Sales and Growth Rate (2019-2025) & (K Units)
Figure 47. India KRAS Inhibitor Sales and Growth Rate (2019-2025) & (K Units)
Figure 48. Southeast Asia KRAS Inhibitor Sales and Growth Rate (2019-2025) & (K Units)
Figure 49. South America KRAS Inhibitor Sales and Growth Rate (K Units)
Figure 50. South America KRAS Inhibitor Sales Market Share by Country in 2023
Figure 51. Brazil KRAS Inhibitor Sales and Growth Rate (2019-2025) & (K Units)
Figure 52. Argentina KRAS Inhibitor Sales and Growth Rate (2019-2025) & (K Units)
Figure 53. Columbia KRAS Inhibitor Sales and Growth Rate (2019-2025) & (K Units)
Figure 54. Middle East and Africa KRAS Inhibitor Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa KRAS Inhibitor Sales Market Share by Region in 2023
Figure 56. Saudi Arabia KRAS Inhibitor Sales and Growth Rate (2019-2025) & (K Units)
Figure 57. UAE KRAS Inhibitor Sales and Growth Rate (2019-2025) & (K Units)
Figure 58. Egypt KRAS Inhibitor Sales and Growth Rate (2019-2025) & (K Units)
Figure 59. Nigeria KRAS Inhibitor Sales and Growth Rate (2019-2025) & (K Units)
Figure 60. South Africa KRAS Inhibitor Sales and Growth Rate (2019-2025) & (K Units)
Figure 61. Global KRAS Inhibitor Production Market Share by Region (2019-2025)
Figure 62. North America KRAS Inhibitor Production (K Units) Growth Rate (2019-2025)
Figure 63. Europe KRAS Inhibitor Production (K Units) Growth Rate (2019-2025)
Figure 64. Japan KRAS Inhibitor Production (K Units) Growth Rate (2019-2025)
Figure 65. China KRAS Inhibitor Production (K Units) Growth Rate (2019-2025)
Figure 66. Global KRAS Inhibitor Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global KRAS Inhibitor Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global KRAS Inhibitor Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global KRAS Inhibitor Market Share Forecast by Type (2025-2032)
Figure 70. Global KRAS Inhibitor Sales Forecast by Application (2025-2032)
Figure 71. Global KRAS Inhibitor Market Share Forecast by Application (2025-2032)
